luca pasquini
luca pasquini
Verified email at iss.it
TitleCited byYear
A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis
C Labbaye, I Spinello, MT Quaranta, E Pelosi, L Pasquini, E Petrucci, ...
Nature Cell Biology 10 (7), 788, 2008
2302008
Circulating haemopoietic and endothelial progenitor cells are decreased in COPD
P Palange, U Testa, A Huertas, L Calabro, R Antonucci, E Petrucci, ...
European Respiratory Journal 27 (3), 529-541, 2006
2062006
The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor
R Riccioni, ML Dupuis, M Bernabei, E Petrucci, L Pasquini, G Mariani, ...
Blood Cells, Molecules, and Diseases 45 (1), 86-92, 2010
1562010
TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL
R Riccioni, L Pasquini, G Mariani, E Saulle, A Rossini, D Diverio, E Pelosi, ...
Haematologica 90 (5), 612-624, 2005
1262005
Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis
E Saulle, A Petronelli, L Pasquini, E Petrucci, G Mariani, M Biffoni, ...
Apoptosis 12 (4), 635-655, 2007
752007
Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma
F Felicetti, A De Feo, C Coscia, R Puglisi, F Pedini, L Pasquini, ...
Journal of translational medicine 14 (1), 56, 2016
712016
A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells
E Petrucci, L Pasquini, A Petronelli, E Saulle, G Mariani, R Riccioni, ...
Gynecologic oncology 105 (2), 481-492, 2007
582007
Discovery of a new family of bis-8-hydroxyquinoline substituted benzylamines with pro-apoptotic activity in cancer cells: Synthesis, structure–activity relationship, and action …
V Moret, Y Laras, T Cresteil, G Aubert, DQ Ping, C Di, ...
European journal of medicinal chemistry 44 (2), 558-567, 2009
562009
Impaired myelopoiesis in mice devoid of interferon regulatory factor 1
U Testa, E Stellacci, E Pelosi, P Sestili, M Venditti, R Orsatti, A Fragale, ...
Leukemia 18 (11), 1864, 2004
402004
MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias
I Spinello, MT Quaranta, R Riccioni, V Riti, L Pasquini, A Boe, E Pelosi, ...
Blood cancer journal 1 (6), e26, 2011
392011
Immunophenotypic features of acute myeloid leukemias overexpressing the interleukin 3 receptor alpha chain
R Riccioni, A Rossini, L Calabrò, D Diverio, L Pasquini, F Lococo, ...
Leukemia & lymphoma 45 (8), 1511-1517, 2004
342004
Salinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell lines
A Calzolari, E Saulle, ML De Angelis, L Pasquini, A Boe, F Pelacchi, ...
PloS one 9 (4), e94438, 2014
332014
High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide
A Petronelli, E Saulle, L Pasquini, E Petrucci, G Mariani, M Biffoni, ...
Cancer letters 282 (2), 214-228, 2009
332009
PLZF-mediated control on c-kit expression in CD34+ cells and early erythropoiesis
I Spinello, MT Quaranta, L Pasquini, E Pelosi, E Petrucci, A Pagliuca, ...
Oncogene 28 (23), 2276, 2009
302009
A small molecule SMAC mimic LBW242 potentiates TRAIL-and anticancer drug-mediated cell death of ovarian cancer cells
E Petrucci, L Pasquini, M Bernabei, E Saulle, M Biffoni, F Accarpio, ...
PloS one 7 (4), e35073, 2012
282012
Podocalyxin is expressed in normal and leukemic monocytes
R Riccioni, A Calzolari, M Biffoni, M Senese, V Riti, E Petrucci, L Pasquini, ...
Blood Cells, Molecules, and Diseases 37 (3), 218-225, 2006
232006
Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells
U Testa, E Petrucci, L Pasquini, G Castelli, E Pelosi
Medicines 5 (1), 16, 2018
222018
Effective erythropoiesis and HbF reactivation induced by kit ligand in β-thalassemia
M Gabbianelli, O Morsilli, A Massa, L Pasquini, P Cianciulli, U Testa, ...
Blood 111 (1), 421-429, 2008
222008
Primary ovarian cancer cells are sensitive to the proaptotic effects of proteasome inhibitors
L Pasquini, A Petronelli, E Petrucci, E Saulle, G Mariani, G Scambia, ...
International journal of oncology 36 (3), 707-713, 2010
182010
Sensitivity and resistance of human cancer cells to TRAIL: mechanisms and therapeutical perspectives
L Pasquini, E Petrucci, R Riccioni, A Petronelli, U Testa
Cancer Ther 4, 47-72, 2006
152006
The system can't perform the operation now. Try again later.
Articles 1–20